United States· US:0143-9753_d67a1656-c53e-45f8-9219-05a53737947f
Methylprednisolone Sodium Succinate
A medicinal product containing methylprednisolone sodium succinate, registered in United States by Hikma Pharmaceuticals USA Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- METHYLPREDNISOLONE SODIUM SUCCINATE
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11014397532525 VIAL, SINGLE-DOSE in 1 CARTON (0143-9753-25) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0143-9753-01)
- ndc110143-9753-25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methylprednisolone sodium succinate in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandMethylprednisolone OrionOrion Corporation
- BelgiumMethylprednisolone Teva 1000 mgTeva Pharma Belgium
- United KingdomMethylprednisolone sodium succinate 125mg powder and solvent for solution for injection vialsPfizer Ltd
- GermanyMethylprednisolon AcisAcis Arzneimittel Gmbh
- CzechiaSOLU-MEDROLPfizer, spol. s r.o., Praha
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Solu-Medrol
- Bulgaria · Метилпреднизолон Чайкафарма
- Czechia · Solu-Medrol
- Germany · Methylprednisolon Hikma, Metypred
- Spain · Urbason
- France · Methylprednisolone Hikma
- United Kingdom (Northern Ireland) · Methylprednisolone Hikma Farmacêutica (Portugal), Methylprednisolone Pfizer
- Hungary · Metilprednizolon Teva
- Italy · Cortrium, Lisamethyle
- Poland · Meprelon
- Portugal · Metilprednisolona Hikma
- Slovakia · Metylprednizolón Hikma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b7fc7eab-4860-4aa4-a0d3-b35ab8eb07a1 GET /v1/drugs/b7fc7eab-4860-4aa4-a0d3-b35ab8eb07a1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR; INTRAVENOUS",
"source": "ndc",
"strength": "40",
"substance": "METHYLPREDNISOLONE SODIUM SUCCINATE",
"productndc": "0143-9753",
"dosage_form": "INJECTION, POWDER, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA203125",
"marketing_category": "ANDA"
}See everything about methylprednisolone sodium succinate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.